The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells.
Miele E, Valente S, Alfano V, Silvano M, Mellini P, Borovika D, Marrocco B, Po A, Besharat ZM, Catanzaro G, Battaglia G, Abballe L, Zwergel C, Stazi G, Milite C, Castellano S, Tafani M, Trapencieris P, Mai A, Ferretti E.
Miele E, et al. Among authors: stazi g.
Oncotarget. 2017 Aug 2;8(40):68557-68570. doi: 10.18632/oncotarget.19782. eCollection 2017 Sep 15.
Oncotarget. 2017.
PMID: 28978137
Free PMC article.